EIF2AK3 and Glucose intolerance: The diverse set of data obtained with opposite pharmacological manipulations of the ISR revealed that ISR activation with HF ameliorates phenotypes in DIO mice whilst inhibition of the ISR with low, ISR-inhibiting doses of PERK inhibitor GSK’157 aggravated glucose intolerance.